Cargando…
The association between polypharmacy and health-related quality of life among non-dialysis chronic kidney disease patients
BACKGROUND AND OBJECTIVE: The United States government spends over $85 billion annually on treating non-dialysis chronic kidney disease (CKD). Patients with CKD are prescribed a multitude of medications to manage numerous comorbidities associated with CKD. Thus, this study aims to investigate the as...
Autores principales: | Adjeroh, Leonie, Brothers, Todd, Shawwa, Khaled, Ikram, Mohammad, Al-Mamun, Mohammad A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642842/ https://www.ncbi.nlm.nih.gov/pubmed/37956162 http://dx.doi.org/10.1371/journal.pone.0293912 |
Ejemplares similares
-
Evaluating the Medication Regimen Complexity Score as a Predictor of Clinical Outcomes in the Critically Ill
por: Al-Mamun, Mohammad A., et al.
Publicado: (2022) -
Quality of life of individuals with chronic kidney disease on
dialysis
por: Jesus, Nadaby Maria, et al.
Publicado: (2019) -
Polypharmacy and Health-Related Quality of Life/Psychological Distress Among Patients With Chronic Disease
por: Van Wilder, Lisa, et al.
Publicado: (2022) -
Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment
por: Pagels, Agneta A, et al.
Publicado: (2012) -
Survival and recovery modeling of acute kidney injury in critically ill adults
por: Brothers, Todd N, et al.
Publicado: (2022)